NDC 0093-8229
Sunitinib Malate
Sunitinib Malate
Sunitinib Malate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Sunitinib Malate.
| Product ID | 0093-8229_6e0b6eab-b0e5-4ef9-9e65-e28159258c67 |
| NDC | 0093-8229 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sunitinib Malate |
| Generic Name | Sunitinib Malate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-12-22 |
| Marketing Category | ANDA / |
| Application Number | ANDA213803 |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Substance Name | SUNITINIB MALATE |
| Active Ingredient Strength | 38 mg/1 |
| Pharm Classes | Protein Kinase Inhibitors [MoA],Kinase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |